🎉 Celebrating Excellence in Peptide Research! 🎉

We proudly announce that Dr. César de la Fuente, from Penn University received the prestigious Miklós Bodánszky Award, presented by the European Peptide Society and sponsored by BCN Peptides.

Dr. de la Fuente is internationally recognised for his pioneering work in using the power of machines to accelerate discoveries in biology and medicine. Specifically, he developed the first computer-designed antibiotic with proven efficacy in animal models, showcasing the application of AI in antibiotic discovery and helping to launch this emerging field. This award highlights his commitment and significant contributions to advancing peptide science and biotechnology.

At BCN Peptides, we are passionate about driving research and development in the field of peptides, and it is an honor to support this award that recognises scientific excellence. Our commitment to innovation and collaboration motivates us to continue supporting great talents, like Dr. de la Fuente, who are making a difference in science and medicine.

Congratulations, Dr. César de la Fuente, on this well-deserved Miklós Bodánszky Award recognition! 👏


hashtag#MiklósBodánszkyAward hashtag#PeptideScience hashtag#AIinBiotech hashtag#Innovation hashtag#ResearchAndDevelopment hashtag#CesarDeLaFuente hashtag#PennUniversity hashtag#Biotechnology hashtag#BCNPeptides hashtag#EuropeanPeptideSociety